China Water Affairs Group Limited (HKG:0855)

Market Cap	9.91B
Revenue (ttm)	11.66B
Net Income (ttm)	1.07B
Shares Out	1.63B
EPS (ttm)	0.66
PE Ratio	9.25
Forward PE	7.77
Dividend	0.28 (4.53%)
Ex-Dividend Date	Sep 25, 2025

Volume	1,988,000
Average Volume	2,712,891
Open	6.17
Previous Close	6.18
Day's Range	6.07 - 6.23
52-Week Range	4.27 - 7.05
Beta	0.56
RSI	40.62
Earnings Date	Aug 29, 2025

About Revance Therapeutics

China Water Affairs Group Limited, an investment holding company, engages in the water supply, environmental protection, and property businesses in the People’s Republic of China. It operates through City Water Supply, Pipeline Direct Drinking Water Supply, Environmental Protection, Main Contractor Construction, and Property Development and Investment segments. The City Water Supply segment is involved in the provision of water supply operation and construction, installation and maintenance, and other services. The Pipeline Direct Drinking Wate...

• Industry: Utilities - Regulated Water
• Sector: Utilities
• Founded: 1999
• Employees: 11,000
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0855

Financial Performance

In 2024, China Water Affairs Group's revenue was 11.66 billion, a decrease of -9.36% compared to the previous year's 12.86 billion. Earnings were 1.07 billion, a decrease of -29.92%.